The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004.

BMC Infectious Diseases
John D MooneyStuart C Clarke

Abstract

For winter 2003/2004 in Scotland, it was recommended that all those aged 65 and over be eligible to receive 23-valent polysaccharide pneumococcal vaccine (23vPPV), which has been shown to be effective in reducing the risk of invasive pneumococcal disease (IPD). We assessed the success of the vaccination programme by examining the age specific incidence rates of IPD compared to four previous winter seasons and estimating vaccination effectiveness. Winter season incidence rates of IPD for vaccine targeted (65 years and over) and non-targeted (0-4, 5-34, 35-49, 50-64) age bands were examined for the Scottish population in a retrospective cohort design for winter 2003/2004. Details of all IPD cases were obtained from the central reference laboratory and population vaccine uptake information was estimated from a GP sentinel practice network. Based on the preceding four winter seasons, standardised incidence ratios (SIR) for invasive pneumococcal disease were determined by age-band and sex during winter 2003/2004. Vaccination effectiveness (VE) was estimated using both screening and indirect cohort methods. Numbers needed to vaccinate were derived from VE results using equivalent annual incidence estimates for winter 2003/2004. Overa...Continue Reading

References

Dec 12, 1977·JAMA : the Journal of the American Medical Association·P SmitM R Hilleman
Nov 21, 1991·The New England Journal of Medicine·E D ShapiroJ D Clemens
Aug 1, 1993·International Journal of Epidemiology·C P Farrington
Oct 20, 1993·JAMA : the Journal of the American Medical Association·J C ButlerR R Facklam
Mar 1, 1996·Social Science & Medicine·M I Gould, K Jones
Jan 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P E KimC E Wright
Dec 1, 1996·Journal of Public Health Medicine·J Womersley
Oct 29, 1997·JAMA : the Journal of the American Medical Association·J E SiskJ C Butler
Aug 11, 1998·The Journal of Infectious Diseases·J B RubinsE N Janoff
Sep 2, 1999·Vaccine·K Mulholland
Jun 8, 2001·Drugs & Aging·J B Rubins, E N Janoff
Feb 16, 1981·Proceedings of the American Philosophical Society·R Austrian
Aug 10, 2002·BMJ : British Medical Journal·Tom Jefferson, Vittorio Demicheli
May 2, 2003·The New England Journal of Medicine·Cynthia G WhitneyUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Moe H KyawHarry Campbell
Oct 30, 2003·The Cochrane Database of Systematic Reviews·K DearD Tatham
Feb 12, 2004·The Lancet Infectious Diseases·Angel Vila CorcolesCarl Llor
Apr 7, 2004·The European Respiratory Journal·B ChristensonA Ortqvist
Jun 9, 2004·American Journal of Respiratory and Critical Care Medicine·Larry M BaddourUNKNOWN International Pneumococcal Study Group
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Angela DominguezJulio Casal
Apr 22, 2005·Public Health Reports·Matthew D RedelingsPaul Simon
Oct 27, 2005·JAMA : the Journal of the American Medical Association·Catherine A LexauUNKNOWN Active Bacterial Core Surveillance Team
Dec 1, 2005·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Lucie McCoyPaul Simon
Jun 3, 2006·Epidemiology and Infection·P MangtaniJ A Roberts
Jun 16, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S M A A EversD S Fedson
Aug 13, 2008·Family Practice·Azeem MajeedAziz Sheikh
Dec 5, 2008·Journal of Public Health·Vanessa AbrahamsonRosalind Raine

❮ Previous
Next ❯

Citations

Dec 15, 2010·Journal of Biomolecular Structure & Dynamics·Aditya Mittal, B Jayaram
Oct 11, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lisa A Jackson, Edward N Janoff
Feb 15, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·David T GilbertsonAllan J Collins
Dec 19, 2012·Médecine et maladies infectieuses·E RouveixUNKNOWN l’intergroupe Société de pathologie infectieuse de langue française/Société de gériatrie et gérontologie clinique (SPILF/SGG
Oct 26, 2012·Human Vaccines & Immunotherapeutics·Pawel GrzesiowskiPierre-Emmanuel Puig
Aug 6, 2011·Respiratory Medicine·Georgia G Pitsiou, Ioannis P Kioumis
Oct 9, 2013·Vaccine·Wallis RudnickUNKNOWN Toronto Invasive Bacterial Diseases Network
Nov 2, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M WoodheadUNKNOWN Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases
Nov 2, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M WoodheadUNKNOWN Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases
May 14, 2016·BMC Pulmonary Medicine·James D ChalmersHarish Madhava
Aug 4, 2011·Expert Review of Vaccines·David S FedsonSandrine I Samson
Oct 30, 2013·Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada·C Quach-ThanhUNKNOWN approved by NACI.
Oct 18, 2014·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·M A Gutierrez RodriguezA Arce Arnaez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.